Maccura Biotechnology completes share cancellation, reduces total capital

Maccura Biotechnology Co., Ltd. announced on September 5, 2025, the completion of the cancellation of 3,958,000 shares held in its special securities account for repurchases. This action reduces the company's total share capital from 608,624,624 shares to 604,666,624 shares, representing a 0.65% decrease from the pre-cancellation total. The company confirmed receipt of the completion notification from China Securities Depository and Clearing Corporation Limited.

The share repurchase and subsequent cancellation followed resolutions passed in February and June 2025. Initially, the repurchased shares were intended for employee stock ownership or equity incentive plans but were later designated for cancellation to reduce registered capital. The total amount paid for the repurchased shares was RMB 50,022,021.82, with an average price of RMB 12.64 per share.

This share capital adjustment does not affect the company's listing qualifications, nor does it change the controlling shareholder or actual controller. The company stated that the cancellation would not have a material impact on its financial position or operating results. The management team will proceed with the necessary industrial and commercial registration changes to reflect the modified registered capital and company articles of association.